- Report
- March 2024
- 196 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- November 2023
- 147 Pages
Global
From €2416EUR$2,499USD£2,076GBP
- Report
- April 2024
- 194 Pages
Global
From €5414EUR$5,600USD£4,653GBP
- Book
- March 2021
- 400 Pages
From €160EUR$165USD£137GBP
- Report
- April 2018
- 80 Pages
Global
From €3190EUR$3,300USD£2,742GBP
- Report
- March 2021
- 25 Pages
Global
€1274EUR$1,318USD£1,095GBP
- Report
- September 2019
Asia Pacific
From €5191EUR$5,370USD£4,462GBP
- Book
- March 2009
- 384 Pages
- Book
- April 2020
- 336 Pages
- Book
- June 2015
- 392 Pages
- Book
- December 2011
- 400 Pages
€1717EUR$1,903USD£1,527GBP
Celiac Disease is a chronic autoimmune disorder of the digestive system that is caused by an adverse reaction to gluten, a protein found in wheat, barley, and rye. It is classified as an allergy and immunology disorder, as it is triggered by an immune response to gluten. Symptoms of Celiac Disease include abdominal pain, bloating, diarrhea, and weight loss. Treatment involves a strict gluten-free diet, which can be difficult to maintain.
The Celiac Disease market is composed of companies that provide products and services related to the diagnosis, treatment, and management of the disorder. These include pharmaceutical companies that develop and market drugs to treat the condition, as well as companies that provide gluten-free food products and services. Additionally, there are companies that provide diagnostic tests and other medical services related to Celiac Disease.
Some companies in the Celiac Disease market include GlaxoSmithKline, Novartis, Pfizer, AbbVie, and Celimmune. Show Less Read more
